Abuse-resistant Adderall fails clinical trial
To view this email as a web page, click here

Today's Rundown

Featured Story

Argenx's subcutaneous Vyvgart matches IV sibling in phase 3, clearing path to FDA filing this year

Argenx’s subcutaneous Vyvgart has hit the primary endpoint in a phase 3 trial, clearing the biotech to file for approval of a formulation it expects to become the most popular version of the autoimmune drug. 

read more

Top Stories

Facing generic rivals, Ipsen starts $66M Somatuline autoinjector project

Ipsen is investing €60 million ($66 million) in an electronic autoinjector for its blockbuster cancer drug Somatuline. Facing generic competition, the French drugmaker has partnered with Phillips-Medisize on a delivery device it expects to enable patients to administer the drug independently at home.

read more

Vallon's abuse-resistant Adderall fails clinical trial, causing stock to crater

Vallon Pharmaceuticals’ abuse-resistant Adderall has flunked a key test. ADAIR performed no better than the reference formulation of the stimulant dextroamphetamine on a measure of abuse liability, causing the trial to miss its primary endpoint and Vallon’s share price to collapse.

read more

With midphase data in hand, MediPrint lands investment to take drug delivery contact lens deeper into the clinic

Investors have bought into MediPrint Ophthalmics’ vision for drug delivery contact lenses. With a phase 2b of its lead glaucoma asset looming into view, MediPrint has pulled together a series A to bankroll its next steps. 

read more

Alnylam sues Pfizer and Moderna claiming infringement on its delivery technology for COVID shots

Alnylam has filed lawsuits claiming COVID-19 vaccine producers Moderna and Pfizer infringed on its patent for a delivery technology employed by both shots. The moves come after Arbutus and Genevant sued Moderna, claiming infringement on the same technology.

read more

Resources

Industry Report: The Top Four Barriers to Successful KOL Engagement

Read why many MSLs are still challenged in developing integrated strategies to increase the volume of meaningful engagements. Download this industry report to find out what the top challenges are and suggestion strategies to solve them. Download now.

eBook: Leveraging Clinical Data for Study Success

The landscape of clinical trials has been permanently changed. Today's trials require sponsors to modernize their use of technology and data to adapt. This eBook provides an overview of how sponsors can empower trials with real-time performance data to improve study integrity, reduce risks, optimize patient safety, and increase trial success rates.

Whitepaper: Autologous CAR T-Cell Manufacturing: Semiautomatic, Closed, Modular Workflow

Learn how to navigate the top manufacturing challenges and achieve a seamless transition from discovery to clinical manufacturing across the CAR T-cell therapy workflow.

eBook: EMEA Regulatory Roadblocks around Decentralized Trials

Learn about ways to break down regulatory roadblocks and get closer to 100% clarity on regulatory positions to advance decentralized clinical trials in research.

Whitepaper: Top 5 Challenges Of Decentralized Clinical Trials And How To Overcome Them

How to overcome top challenges faced in decentralized trials.

Paid Marketplace: United Cargo: Providing comprehensive solutions for the most critical shipments

The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now.

Whitepaper: The Most Suitable Dosage Form Technologies for the Oral Delivery of Lipid-Based Formulations

What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations?

Case Study: Versatility of Softgel Technology - Encapsulation of a Volatile Compound

Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound.

Whitepaper: Lipid-Based Drug Delivery System to Bring Poorly Soluble Drugs to Market

How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market?

Whitepaper: Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial

Sites receiving augmentation support enroll more than 30,000 patients in just over three months. See how additional site resources can make a difference.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

Events